Gillian has been lucky among the most unluckiest. In 2017, she was 1 of 1000 diagnosed with Osteosarcoma in the US. While she thrives, we have lost friends to this rare disease and many others are still fighting. Help us end this game of chance.
The standard treatment protocol is over 40 years old. Only 8% of cancer funding is earmarked for all childhood cancers combined. Gillian had to endure 9 months of intense chemotherapy, 9 surgeries, and many painful setbacks.
We are grateful to our doctors, nurses, therapists, friends, and family that today she is healthy and can walk. But mostly, she stands as she creates art.
Please stand with us to advocate for more research. Join us as we honor the memories of Ally and Adriana. Help us support patients, families, caregivers, and health professionals who fight against the odds.
#TeamGOAT #LiveLikeAlly #BecauseOfGillian
FACTOR brings together the leading researchers, clinicians, surgeons, together with patient families and OsteoWarriors to Make It Better for those battling this disease.
Each year a grant of $100,000 is awarded to a project that will focus on moving research forward for osteosarcoma patients.
Browse our extensive list of osteosarcoma resources from MIB Agents and our partner organizations.
OsteoBites is a weekly webinar and podcast where we invite Osteosarcoma Experts and OsteoWarriors to share their research, hope, and innovation.
Agent GAMERS game with their fellow OsteoWarriors and OsteoSiblings.
Ambassador Agents are certified peer visitors who provide hope, understanding, and resources.
OsteoWarriors receive monthly letters of hope and cheer from MIB Agent Writers around the world.
When an OsteoWarrior transitions to hospice care, MIB Agents provides an experience or an item of comfort and entertainment.
The OsteoWarriors HQ (headquarters) brings kids and young adults who have a connection to osteosarcoma together and It. Is. Awesome!
A world with less toxic, more effective treatments and a cure for osteosarcoma.
We are devoted to creating and instilling hope with and for our inclusive and collaborative osteosarcoma community. We do this through mutual trust, transparency and compassion.
